DG051
Product Specifications
UNSPSC Description
DG051 is a potent leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis in the enzyme assay with an IC50=47 nM.
Target Antigen
Aminopeptidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/DG051.html
Purity
99.86
Solubility
DMSO : ≥ 325 mg/mL
Smiles
Cl[H].O=C(O)CCCN1CCC[C@H]1COC(C=C2)=CC=C2OC3=CC=C(Cl)C=C3
Molecular Weight
426.33
References & Citations
[1]Sandanayaka V, et al. Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis. J Med Chem. 2010 Jan 28;53(2):573-85.|[2]Enache LA, et al. Synthesis and structural assignment of two major metabolites of the LTA4H inhibitor DG-051. Bioorg Med Chem Lett. 2009 Nov 15;19(22):6275-9.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-10825/DG051-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-10825/DG051-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
929915-58-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1042496-01 0.02 mg (E-Coli)
Recombinant Shewanella pealeana Putative reductase Spea_2676 (Spea_2676)
Ask
View Details MBS1042496-02 0.02 mg (Yeast)
Recombinant Shewanella pealeana Putative reductase Spea_2676 (Spea_2676)
Ask
View Details